GENETIC LEVERAGE: what changed
GENETIC LEVERAGE
Largest movements
- Cash -€5,161
down €5,161 (-6.6%), from €78,717 to €73,556
mainly Net result for the year (-€2,816) and Trade debts (-€2,345)
- Profit (loss) carried forward -€2,816
down €2,816 (-1.5%), from -€182,193 to -€185,009
- Trade debts -€2,345
down €2,345 (-92.8%), from €2,526 to €182
- Gross operating margin +€7,862
up €7,862 (+80.0%), from -€9,821 to -€1,959
- Other operating charges -€261
down €261 (-27.8%), from €939 to €678
- Financial charges +€122
up €122 (+214%), from €57 to €179
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €78,717 | €73,556 | -€5,161 | -6.6% |
| Current assets | 29/58 | €78,717 | €73,556 | -€5,161 | -6.6% |
| Cash at bank and in hand | 54/58 | €78,717 | €73,556 | -€5,161 | -6.6% |
| Total equity and liabilities | 10/49 | €78,717 | €73,556 | -€5,161 | -6.6% |
| Equity | 10/15 | €8,928 | €6,112 | -€2,816 | -31.5% |
| Contributions | 10/11 | €6,197 | €6,197 | = | 0.0% |
| Capital | 10 | €6,197 | €6,197 | = | 0.0% |
| Issued capital | 100 | €18,592 | €18,592 | = | 0.0% |
| Uncalled capital | 101 | €12,395 | €12,395 | = | 0.0% |
| Reserves | 13 | €184,924 | €184,924 | = | 0.0% |
| Distributable reserves | 133 | €184,924 | €184,924 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€182,193 | -€185,009 | -€2,816 | -1.5% |
| Amounts payable | 17/49 | €69,789 | €67,444 | -€2,345 | -3.4% |
| Amounts payable after more than one year | 17 | €61,590 | €61,590 | = | 0.0% |
| Financial debts | 170/4 | €61,590 | €61,590 | = | 0.0% |
| Amounts payable within one year | 42/48 | €8,199 | €5,854 | -€2,345 | -28.6% |
| Trade debts | 44 | €2,526 | €182 | -€2,345 | -92.8% |
| Suppliers | 440/4 | €2,526 | €182 | -€2,345 | -92.8% |
| Other amounts payable | 47/48 | €5,673 | €5,673 | = | 0.0% |
| Other operating charges | 640/8 | €939 | €678 | -€261 | -27.8% |
| Gross operating margin | 9900 | -€9,821 | -€1,959 | +€7,862 | +80.0% |
| Operating profit (loss) | 9901 | -€10,759 | -€2,637 | +€8,122 | +75.5% |
| Financial charges | 65/66B | €57 | €179 | +€122 | +214% |
| Recurring financial charges | 65 | €57 | €179 | +€122 | +214% |
| Profit (loss) for the period before taxes | 9903 | -€10,816 | -€2,816 | +€8,000 | +74.0% |
| Profit (loss) for the period | 9904 | -€10,816 | -€2,816 | +€8,000 | +74.0% |
| Profit (loss) for the period to be appropriated | 9905 | -€10,816 | -€2,816 | +€8,000 | +74.0% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 29 February 2024 and 28 February 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.